LIMK1 and neuroblastoma: Relative to a non-targeting control (NTC) oligonucleotide, both forms of LIMK knockdown significantly reduced neuroblastoma cell viability in SK-N-AS cells (Figure 10D) and SK-N-SH cells (Figure 10E).